Inhibition of DNA-PK activity and radio-sensitization induced by single strand DNA
单链 DNA 诱导的 DNA-PK 活性抑制和放射增敏作用
基本信息
- 批准号:15390357
- 负责人:
- 金额:$ 8.77万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Phosphorothioate oligonucleotides and suramin bind to heparin binding proteins including DNA polymerases, and inhibit their functions. In the present study, we report inhibition of DNA-dependent protein kinase (DNA-PK) activity by phosphorothioate oligonucleotides and suramin. Inhibitory effect of phosphorothioate oligonucleotides on DNA-PK activity was increased with length and reached a plateau at 36-mer. The base composition of phosphorothioate oligonucleotides did not affect the inhibitory effect. The inhibitory effect by phosphorothioate oligodeoxycytidine 36-mer can be about 200-fold greater than that by the phosphodiester oligodeoxycytidine 36-mer. The inhibitory effect was also observed with purified DNA-PK, which suggests direct interaction between DNA-PK and phosphorothioate oligonucleotides. DNA-PK will have different binding positions for double-stranded DNA and phosphorothioate oligodeoxycytidine 36-mer because they were not competitive in DNA-PK activation. Suramin sensit … More ized cells to X-radiation in a dose-dependent fashion and longer exposure to suramin before X-irradiation resulted in more efficient sensitization. The dose-modifying factors calculated from the survival curves were 1.18 in LM217 cells and 1.37 in MDA-MB-468 cells. Suramin did not sensitized scid cells that had no DNA-dependent protein kinase activity. Suramin inhibited DNA-dependent protein kinase activity in vitro and in vivo. The concentration of suramin resulting in 50% inhibition in vitro was 1.7 μM in LM217 cells and 2.4 μM in MDA-MB-468 cells. Exposure of LM217 and MDA-MB-468 cells to suramin did not affect the level of Ku70 or Ku80, but it increased the level of DNA-PKcs. Suramin did not sensitize LM217 or MDA-MB-468 cells to UV radiation. Exposure to suramin inhibited the repair of DNA double-strand breaks caused by 50 Gy irradiation. Suramin's effects were not caused by accumulation of cells in a specific phase of the cell cycle. These results suggest that suramin sensitizes cells to ionizing radiation by inhibiting DNA-dependent protein kinase activity. Less
硫代磷酸酯寡核苷酸和苏拉明与包括 DNA 聚合酶在内的肝素结合蛋白结合,并抑制其功能。在本研究中,我们报告了硫代磷酸寡核苷酸和苏拉明对 DNA 依赖性蛋白激酶 (DNA-PK) 活性的抑制作用。硫代磷酸寡核苷酸对 DNA-PK 活性的抑制作用随着长度的增加而增加,并在 36 聚体处达到稳定水平。硫代磷酸寡核苷酸的碱基组成不影响抑制效果。硫代磷酸酯寡脱氧胞苷36聚体的抑制效果可以比磷酸二酯寡脱氧胞苷36聚体的抑制效果大约200倍。纯化的 DNA-PK 也观察到了抑制作用,这表明 DNA-PK 和硫代磷酸酯寡核苷酸之间存在直接相互作用。 DNA-PK 对于双链 DNA 和硫代磷酸寡脱氧胞苷 36 聚体将具有不同的结合位置,因为它们在 DNA-PK 激活中不具有竞争性。苏拉明以剂量依赖性方式使细胞对 X 辐射敏感,并且在 X 辐射之前较长时间接触苏拉明会导致更有效的敏化。从生存曲线计算出的剂量修改因子在LM217细胞中为1.18,在MDA-MB-468细胞中为1.37。苏拉明不会使不具有 DNA 依赖性蛋白激酶活性的 scid 细胞致敏。苏拉明在体外和体内抑制 DNA 依赖性蛋白激酶活性。在 LM217 细胞中产生 50% 体外抑制的苏拉明浓度为 1.7 μM,在 MDA-MB-468 细胞中为 2.4 μM。将 LM217 和 MDA-MB-468 细胞暴露于苏拉明不会影响 Ku70 或 Ku80 的水平,但会增加 DNA-PKcs 的水平。苏拉明不会使 LM217 或 MDA-MB-468 细胞对紫外线辐射敏感。暴露于苏拉明可抑制 50 Gy 辐射引起的 DNA 双链断裂的修复。苏拉明的作用不是由细胞周期特定阶段的细胞积累引起的。这些结果表明,苏拉明通过抑制 DNA 依赖性蛋白激酶活性使细胞对电离辐射敏感。较少的
项目成果
期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hosoi, Y.: "Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC."Molecular Carcinogenesis. (in press).
Hosoi, Y.:“通过共济失调毛细血管扩张 D 组互补基因 ATDC 的表达来抑制锚定非依赖性生长。”分子癌发生。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Basics of combined chemo-radiotherapy.
联合放化疗的基础知识。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Hosoi Y;et al.;Hosoi Y.
- 通讯作者:Hosoi Y.
Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation
- DOI:10.1016/j.bbrc.2005.12.193
- 发表时间:2006-03-10
- 期刊:
- 影响因子:3.1
- 作者:Li, ZP;Hosoi, Y;Miyagawa, K
- 通讯作者:Miyagawa, K
Komuro, Y.: "Prediction of tumor radiosensitivity in rectal carcinoma based on p53 and Ku70 expression."J.Exp.Clin.Cancer Res.. 22. 223-228 (2003)
Komuro, Y.:“基于 p53 和 Ku70 表达预测直肠癌肿瘤放射敏感性。”J.Exp.Clin.Cancer Res.. 22. 223-228 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOSOI Yoshio其他文献
HOSOI Yoshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOSOI Yoshio', 18)}}的其他基金
Radiosensitization of radioresistant cancer stem cells by inhibition of ATM
通过抑制 ATM 实现抗辐射癌症干细胞的放射增敏
- 批准号:
23659588 - 财政年份:2011
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Radiation sensitization though regulation of transcriptional factor Sp1
通过转录因子 Sp1 的调节实现放射增敏
- 批准号:
18390330 - 财政年份:2006
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inhibition of DNA-PK activity by phosphorothioate oligonucleotides
硫代磷酸酯寡核苷酸对 DNA-PK 活性的抑制
- 批准号:
12470184 - 财政年份:2000
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effect of a phosphatidylinositol 3-kinase inhibitor wortmannin on radiation and bleomycin sensitivities.
磷脂酰肌醇 3-激酶抑制剂渥曼青霉素对辐射和博莱霉素敏感性的影响。
- 批准号:
09670911 - 财政年份:1997
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
病毒诱导的DNA损伤反应中DNA-PK介导自噬影响病毒复制的分子机制
- 批准号:32372988
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
去泛素化酶Otud1调控Ssbp1/DNA-PK在心肌肥厚中的作用及机制研究
- 批准号:82360085
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
DNA-PK调控的初级纤毛发生介导胶质母细胞瘤重离子辐射抵抗的作用机制研究
- 批准号:12375355
- 批准年份:2023
- 资助金额:53.00 万元
- 项目类别:面上项目
靶向DNA-PK克服非小细胞肺癌三代EGFR-TKI获得性耐药的作用和机制研究
- 批准号:82272672
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向DNA-PK介导的NHEJ途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
结肠癌细胞内Geminin/DNA-PK相互作用增强顺铂化疗损伤耐受及其干预策略的研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
EBV-LMP1通过DNA-PK/AMPK相互作用调控鼻咽癌放射敏感性的分子机制
- 批准号:2020JJ4899
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
抑制DNA-PK基因影响电离辐射诱导DNA双链断裂非同源末端连接修复的研究
- 批准号:2020A1515010282
- 批准年份:2020
- 资助金额:10.0 万元
- 项目类别:省市级项目
p54nrb/RPLP0复合物磷酸化 DNA-PK促进肿瘤放疗抵抗的分子机制
- 批准号:2020A1515010315
- 批准年份:2020
- 资助金额:10.0 万元
- 项目类别:省市级项目
DNA-PK激酶复合体调节肿瘤疱疹病毒KSHV复制的分子机制
- 批准号:31970156
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
Development of clinical candidate hypoxia-activated DNA-PK inhibitors
临床候选缺氧激活 DNA-PK 抑制剂的开发
- 批准号:
490356 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Operating Grants
Development of DNA-PK-targeting PROTACs to maximise DNA-PK blockage in advanced prostate cancer
开发 DNA-PK 靶向 PROTAC 以最大限度地阻断晚期前列腺癌的 DNA-PK
- 批准号:
2877287 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Studentship
Investigating the interaction between DNA-PK, cGAS and IFI16 in the innate immune response pathway
研究先天免疫反应途径中 DNA-PK、cGAS 和 IFI16 之间的相互作用
- 批准号:
2737806 - 财政年份:2022
- 资助金额:
$ 8.77万 - 项目类别:
Studentship
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10364056 - 财政年份:2022
- 资助金额:
$ 8.77万 - 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10553146 - 财政年份:2022
- 资助金额:
$ 8.77万 - 项目类别:
Liver Cancer - Developing DNA-PK as a predictive biomarker and clinical target
肝癌 - 开发 DNA-PK 作为预测生物标志物和临床靶点
- 批准号:
2601970 - 财政年份:2021
- 资助金额:
$ 8.77万 - 项目类别:
Studentship
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition
Ku 靶向小分子抑制剂的发现和开发:DNA-PK 抑制的新机制
- 批准号:
10581526 - 财政年份:2020
- 资助金额:
$ 8.77万 - 项目类别:
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition
Ku 靶向小分子抑制剂的发现和开发:DNA-PK 抑制的新机制
- 批准号:
10358629 - 财政年份:2020
- 资助金额:
$ 8.77万 - 项目类别:
Biological Significance of DNA-PK in the Orchestration of Cellular Response to DNA Double-strand Breaks
DNA-PK 在协调细胞对 DNA 双链断裂反应中的生物学意义
- 批准号:
20H04334 - 财政年份:2020
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DNA-PK-DNA complexes - the molecular mechanism triggering differentiated DNA Damage Repair signaling pathways
DNA-PK-DNA 复合物 - 触发差异化 DNA 损伤修复信号通路的分子机制
- 批准号:
BB/S50726X/1 - 财政年份:2018
- 资助金额:
$ 8.77万 - 项目类别:
Training Grant